株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の創薬アウトソーシング市場:2017年〜2027年の予測 - 化学サービス、生物学サービス、リード最適化、リード識別、スクリーニング

Drug Discovery Outsourcing Market Forecast 2017-2027: Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies

発行 Visiongain Ltd 商品コード 260308
出版日 ページ情報 英文 225 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=155.10円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
世界の創薬アウトソーシング市場:2017年〜2027年の予測 - 化学サービス、生物学サービス、リード最適化、リード識別、スクリーニング Drug Discovery Outsourcing Market Forecast 2017-2027: Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies
出版日: 2017年10月13日 ページ情報: 英文 225 Pages
概要

世界の創薬アウトソーシング市場の収益は、2017年に210億米ドルを上回り、2027年まで目覚ましい成長を遂げると予測されています。

当レポートでは、世界の創薬アウトソーシング市場について調査分析し、収益予測に焦点を当てて、データ、動向、機会、ビジネスの見通しなど、体系的な情報を提供しています。

第1章 レポート概要

第2章 創薬アウトソーシングのイントロダクション

  • アウトソーシングとは
  • 創薬アウトソーシングとは
  • 創薬をアウトソーシングする理由
  • 一般的な創薬モデル (産学協同を含む)
  • 創薬のアウトソーシングモデルがイノベーションを牽引
  • 創薬におけるアウトソーシングプロセス
  • 創薬アウトソーシングにおける課題
  • 新興市場はCROに人気
  • 買収に向けた戦略的提携
  • 最新の創薬アウトソーシング契約

第3章 世界の創薬アウトソーシング市場とサービス分野の二次市場

  • 創薬アウトソーシング:世界市場の概要
  • 世界の創薬アウトソーシング市場部門
  • 世界の創薬アウトソーシング市場:部門別
  • 市場シェアの変化:部門別
  • 世界の化学サービスアウトソーシング市場
  • 世界の生物学サービスアウトソーシング市場
  • 世界のリード化合物最適化市場
  • 世界のリード化合物探索・スクリーニングアウトソーシング市場

第4章 創薬アウトソーシング市場における主要国市場

  • 創薬アウトソーシングの概要
  • 創薬アウトソーシング市場における主要国市場
  • 創薬アウトソーシング市場における主要国市場の市場シェアの変化
  • 創薬アウトソーシング市場における主要国市場のCAGR
  • 米国
  • EU5ヶ国
  • 日本
  • 中国
  • インド
  • ブラジル
  • ロシア
  • 韓国
  • メキシコ
  • その他

第5章 創薬アウトソーシング市場における主要企業

  • 創薬アウトソーシング:断片的・成長市場
  • 主要CROの特徴
  • 創薬アウトソーシング市場における主要企業のサービス提供
  • Albany Molecular Research (AMRI)
  • Aptuit
  • Charles River Laboratories
  • Covance (Laboratory Corporation of Americaが買収)
  • Cyprotex
  • Domainex
  • Evotec
  • GenScript
  • Pharmaceutical Product Development (PPD)
  • QuintilesIMS
  • Selcia
  • Viva Biotech
  • WIL Research Laboratories
  • WuXi Apptec

第6章 創薬アウトソーシング市場の定性分析

  • 創薬アウトソーシング市場における促進要因と抑制要因
  • 創薬アウトソーシング市場のSWOT分析
  • 強み
  • 弱み
  • 機会
  • 脅威
  • 創薬アウトソーシング市場のファイブフォース分析

第7章 結論

第8章 用語集

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0246

Drug Discovery Outsourcing - our new study reveals trends, R&D progress, and predicted revenues

Where is the Drug Discovery Outsourcing market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 225-page report provides 150 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Drug Discovery Outsourcing market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there forecasts for 4 Drug Discovery Submarkets,

Global Drug Discovery Outsourcing Submarkets

  • Chemistry Services
  • Biology Services
  • Lead Optimisation
  • Lead Identification and Screening

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 13 leading national markets:

  • The US
  • Germany
  • The UK
  • Italy
  • Spain
  • France
  • Russia
  • Japan
  • South Korea
  • China
  • India
  • Brazil
  • Mexico

The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, India, Brazil and Mexico in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Drug Discovery Outsourcing will surpass $21bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Drug Discovery Outsourcing Market report helps you

In summary, our 225-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the Drug Discovery Outsourcing market, with forecasts for 4 submarkets, each forecasted at a global level - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 13 key national markets - See forecasts for the Drug Discovery Outsourcing market in the US, Mexico, Brazil, Germany, France, the UK, Italy, Spain, Russia, China, India, Japan, and South Korea
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Drug Discovery Outsourcing market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Drug Discovery Outsourcing market and leading companies. You will find data, trends and predictions.

Get our report today Drug Discovery Outsourcing Market Forecast 2017-2027: Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. The Drug Discovery Outsourcing Market Overview
  • 1.2. Drug Discovery Outsourcing Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who is This Report For?
  • 1.7. Methodology
  • 1.8. Frequently Asked Questions(FAQ)
  • 1.9. Associated Reports
  • 1.10. About Visiongain

2. An Introduction to Drug Discovery Outsourcing

  • 2.1. What is Outsourcing?
  • 2.2. What is Drug Discovery Outsourcing?
  • 2.3. Why Outsource Drug Discovery?
  • 2.4. A Common Drug Discovery Model Includes Pharmaceutical Organizations Collaborating with Academia
  • 2.5. The Outsource Model for Drug Development Increases Innovation
  • 2.6. Outsourced Processes in Drug Discovery
  • 2.7. Challenges with Drug Discovery Outsourcing
  • 2.8. Emerging Markets are a Popular Destination for CROs
  • 2.9. Strategic Partnerships to Acquisitions
  • 2.10. Recent Drug Development Outsourcing Agreements

3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2017-2027

  • 3.1. Drug Discovery Outsourcing: Global Market Overview
  • 3.2. The Global Drug Discovery Outsourcing Market Sectors
  • 3.3. The Global Drug Discovery Outsourcing Market by Sector, 2016
  • 3.4. The Global Drug Discovery Outsourcing Market by Sector, 2016-2027
  • 3.5. The Changing Market Shares by Sector, 2016-2027
  • 3.6. The Global Chemistry Services Outsourcing Market, 2016
    • 3.6.1. Libraries
    • 3.6.2. Building Blocks
    • 3.6.3. Compound Synthesis
    • 3.6.4. The Global Chemistry Services Outsourcing Market Forecast, 2016-2027
  • 3.7. The Global Biology Services Outsourcing Market, 2016
    • 3.7.1. Target Identification
    • 3.7.2. Target Validation
    • 3.7.3. The Global Biology Services Outsourcing Market Forecast, 2016-2027
  • 3.8. The Global Lead Optimisation Market, 2016
    • 3.8.1. ADMET Screening: Prevents Late Stage Failure of Clinical Trials
    • 3.8.2. The Global Lead Optimisation Market Forecast, 2016-2027
  • 3.9. The Global Lead Identification and Screening Outsourcing Market, 2016
    • 3.9.1. Methods of Screening in Drug Discovery
    • 3.9.2. Primary Screening
    • 3.9.3. The Global Lead Identification and Screening Outsourcing Market Forecast, 2016-2027

4. The Leading National Markets in the Drug Discovery Outsourcing Market 2016-2027

  • 4.1. Drug Discovery Outsourcing Overview
  • 4.2. The Leading National Markets in the Drug Discovery Outsourcing Market, 2016
  • 4.3. The Leading National Markets in the Drug Discovery Outsourcing Market, 2016-2027
  • 4.4. The Changing Market Shares of the Leading National Markets in the Drug Discovery Outsourcing Market, 2016-2027
  • 4.5. CAGRs of the Leading National Markets in the Drug Discovery Outsourcing Market, 2016-2027
  • 4.6. The US Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
  • 4.7. The EU5 Drug Discovery Outsourcing Market by Region, 2016
    • 4.7.1. The EU5 Drug Discovery Outsourcing Market Forecast, 2016-2027
    • 4.7.2. CAGRs by EU5 Region, 2016-2027
    • 4.7.3. The EU5 Changing Market Shares by Country 2017-2027
      • 4.7.3.1. The German Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
      • 4.7.3.2. The UK Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
      • 4.7.3.3. The French Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
      • 4.7.3.4. The Italian Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
      • 4.7.3.5. The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
  • 4.8. The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
  • 4.9. The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
    • 4.9.1. Challenges to China's Growth
  • 4.10. The Indian Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
  • 4.11. The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
  • 4.12. The Russian Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
  • 4.13. The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2016-2027
  • 4.14. The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2017-2027
  • 4.15. The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2016-2027

5. Leading Companies in the Drug Discovery Outsourcing Market

  • 5.1. Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
  • 5.2. Characteristics of Leading Contract Research Organisations
    • 5.2.1. A Highly Quality Workforce
    • 5.2.2. Emphasis on Intellectual Property Protection
    • 5.2.3. Long Term Working Relationship
    • 5.2.4. Success in Project Completion
    • 5.2.5. Internal Drug Discovery Programmes
  • 5.3. Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
  • 5.4. Albany Molecular Research(AMRI)
    • 5.4.1. Historical Sales and Recent Financial Performance, 2013-2016
    • 5.4.2. AMRI's Drug Discovery Services
    • 5.4.3. Internal Portfolio of Drug Discovery and Development Programme Collaborations
    • 5.4.4. AMRI(DDS) Sales Forecast, 2016-2027
  • 5.5. Aptuit
    • 5.5.1. INDIGO: Accelerating Early Drug Candidates
    • 5.5.2. Aptuit Clinical Trial Supplies
    • 5.5.3. Strategic Partnerships, Acquisitions and Divestitures
      • 5.5.3.1. Divestiture of Aseptic Clinical Manufacturing
      • 5.5.3.2. Aptuit's Extended Partnership with GSK for Verona Centre
      • 5.5.3.3. Partnership with Siena Biotech
      • 5.5.3.4. Partnership with Laurus Labs
      • 5.5.3.5. Partnership with Regulus Therapeutics Inc.
      • 5.5.3.6. Partnership with Chronos Therapeutics
      • 5.5.3.7. Partnership with Chiesi Farmaceutici
      • 5.5.3.8. Partnership with SAMDI Tech, Inc.
  • 5.6. Charles River Laboratories
    • 5.6.1. Historical Sales and Financial Performance, 2013-2016
    • 5.6.2. Charles River Laboratories: An External Acquisition Strategy
      • 5.6.2.1. Acquisition of ChanTest
      • 5.6.2.2. Acquisition of Galapagos' CRO Services Division(BioFocus and Argenta)
      • 5.6.2.3. Acquisition of VivoPath
      • 5.6.2.4. Partnership with Chiesi Farmaceutici SpA
      • 5.6.2.5. Partnership with Nimbus Therapeutics
    • 5.6.3. Charles River Laboratories: Revenue and Financial Analysis, 2016
      • 5.6.3.1. Charles River Laboratories: Historical Financial Performance by Business Segment, 2014-2016
    • 5.6.4. Charles River Laboratories Sales Forecast, 2016-2027
  • 5.7. Covance(Acquired by Laboratory Corporation of America)
    • 5.7.1. Covance: Historical Revenue and Financial Performance, 2010-2013
    • 5.7.2. Covance: Early Stage Discovery Efforts
    • 5.7.3. Agreement with Sanofi
    • 5.7.4. Agreement with Kellogg Company
    • 5.7.5. Agreement with Bio Pontis Alliance
    • 5.7.6. Agreement with Indiana Clinical and Translational Sciences Institute(CTSI)
    • 5.7.7. Agreement with Eli Lilly
  • 5.8. Cyprotex
    • 5.8.1. Historical Revenue and Financial Performance, 2011-2014
    • 5.8.2. Cyprotex: Revenue by Region, 2015
  • 5.9. Domainex
    • 5.9.1. Drug Pipeline
    • 5.9.2. TBK1/ IKKε-Inhibitors
    • 5.9.3. Methyltransferase(KMTS) Inhibitors
  • 5.10. Evotec
    • 5.10.1. Strategic Action Plan
    • 5.10.2. Evotec: Historical Revenue and Financial Analysis, 2013-2016
    • 5.10.3. EVT Integrate and EVT Innovate
    • 5.10.4. Partnerships with Pharma for Drug Discovery
      • 5.10.4.1. Partnership with Sanofi
      • 5.10.4.2. Extended Partnership with Evotec
      • 5.10.4.3. Partnership with Johnson & Johnson
      • 5.10.4.4. Partnership with AstraZeneca
      • 5.10.4.5. Partnership with Bayer Pharmaceuticals
      • 5.10.4.6. Partnership with Boehringer Ingelheim Pharma
      • 5.10.4.7. Collaboration with CHDI
      • 5.10.4.8. Collaboration with Janssen
      • 5.10.4.9. Collaboration with MedImmune
      • 5.10.4.10. Collaboration with UCB Pharma
    • 5.10.5. Evotec Sales Forecast, 2015-2026
  • 5.11. GenScript
    • 5.11.1. GenScript: Agreements and Partnerships
  • 5.12. Pharmaceutical Product Development(PPD)
    • 5.12.1. PPD: Agreements, Strategic Partnerships and Private Merger
      • 5.12.1.1. Acquisition of Acurian
      • 5.12.1.2. Partnership with Elan
      • 5.12.1.3. Partnership with GSK
  • 5.13. QuintilesIMS
    • 5.13.1. QuintilesIMS: Historical Revenue and Financial Performance, 2013-2016
    • 5.13.2. Development Deal With Merck
    • 5.13.3. QuintilesIMS: Acquisition of Advion Bioanalytical Labs
    • 5.13.4. QuintilesIMS: Shedding Jobs
    • 5.13.5. Merger with IMS
    • 5.13.5. QuintilesIMS Sales Forecast, 2016-2027
  • 5.14. Selcia
    • 5.14.1. A Strong Natural Product Chemistry Track Record
    • 5.14.3. Collaboration with Cantab
  • 5.15. Viva Biotech
    • 5.15.1. GPCR Targeted Discovery Programs
    • 5.15.2. Antibody Therapeutics Discovery
  • 5.16. WIL Research Laboratories
    • 5.16.1. Focus on Preclinical Research
    • 5.16.2. Acquisition of Ricerca Biosciences LLC
    • 5.16.3. Acquisition of Midwest Bio Research
  • 5.17. WuXi Apptec
    • 5.17.1. WuXi AppTec: Service Offerings
    • 5.17.2. Acquisition of Next CODE Health
    • 5.17.3. WuXiAppTec: Historical Revenue and Financial Performance, 2010-2014
    • 5.17.4. WuXiAppTec: Laboratory Services Sales Forecast, 2015-2026

6. Qualitative Analysis of the Drug Discovery Outsourcing Market, 2017-2027

  • 6.1. Drivers and Restraints in the Drug Discovery Outsourcing Market, 2017-2027
  • 6.2. SWOT Analysis of the Drug Discovery Outsourcing Market, 2017-2027
  • 6.3. Strengths
    • 6.3.1. Cost Reduction: A Central Driver for Outsourcing
    • 6.3.2. Accelerating the Discovery of Drug Candidates
    • 6.3.3. Growth of Virtual Pharmaceutical Companies
    • 6.3.4. Reduction in R&D capacity Within Big Pharma
  • 6.4. Weaknesses
    • 6.4.1. Slowing Trajectory of Growth for R&D Spending
    • 6.4.2. Increasingly Saturated Market Requires Companies to Quickly Evolve
  • 6.5. Opportunities
    • 6.5.1. The Available Scope for the Expansion of CROs
    • 6.5.2. Targeted Therapies: Advances in Biologics and Orphan Drugs
    • 6.5.3. Increasing Development of Biologics and Biosimilars
  • 6.6. Threats
    • 6.6.1. A Competitive Market is Increasing Consolidation
    • 6.6.2. Threat of Private Public Alliances
    • 6.6.3. Intellectual Property Leaks
    • 6.6.4. Challenges of Technology Transfer
  • 6.7. Porter's Five Force Analysis of the Drug Discovery Outsourcing Market
    • 6.7.1. Threat of New Entrants: Medium
    • 6.7.2. Power of Suppliers: Medium
    • 6.7.3. Threat of Substitutes: Medium
    • 6.7.4. Power of Buyers: High
    • 6.7.5. Rivalry Among Competitors: High

7. Conclusion

  • 7.1. Market Overview
  • 7.2. Lead Optimisation will be the Fastest Growing Sector
  • 7.3. The Drug Discovery Outsourcing Market in Emerging Market Shows Huge Gains
  • 7.4. Continued Growth in Alliances and Collaborations
  • 7.5. Concluding Remarks

8. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 1.1: The Drug Discovery Outsourcing Market: Overview of Submarkets
  • Figure 2.1: Selected Tasks being Outsourced in the Pharma Industry, 2016
  • Figure 2.2: Stages of the Drug Development Cycle
  • Figure 3.1: PhMRA's Historical Estimate for its Member's Total R&D Spending($bn), 1980-2015
  • Figure 3.2: Attrition Rate of Compounds at the Developmental Stages
  • Figure 3.3: The Global Drug Discovery Outsourcing Market: Revenue($bn) by Sector, 2016
  • Figure 3.4: The Global Drug Discovery Outsourcing Market: Market Share(%) by Sector, 2016
  • Figure 3.5: The Global Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 3.6: The Global Drug Discovery Outsourcing Market: Market Shares(%) by Sector, 2022
  • Figure 3.7: The Global Drug Discovery Outsourcing Market: Market Shares(%)by Sector, 2027
  • Figure 3.8: The Chemistry Services Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 3.9: The Biology Services Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 3.10: An Overview of ADMET Screening in Drug Discovery
  • Figure 3.11: The Lead Optimisation Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 3.12: Typical Steps in the Lead Screening Process
  • Figure 3.13: The Lead Identification and Screening Outsourcing Market a Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.1: The Global Drug Discovery Outsourcing Market: Revenue($bn) by Region, 2016
  • Figure 4.2: The Global Drug Discovery Outsourcing Market: Market Share(%) by Region, 2016
  • Figure 4.3: The Global Drug Discovery Outsourcing Market: Market Share(%) by Region, 2022
  • Figure 4.4: The Global Drug Discovery Outsourcing Market: Market Share(%) by Region, 2027
  • Figure 4.5: The Global Drug Discovery Outsourcing Market Forecast: CAGR(%) by Region, 2017-2022
  • Figure 4.6: The Global Drug Discovery Outsourcing Market Forecast: CAGR(%) by Region, 2022-2027
  • Figure 4.7: The Global Drug Discovery Outsourcing Market Forecast: CAGR(%) by Region, 2017-2027
  • Figure 4.8: The US Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.9: The EU5 Drug Discovery Outsourcing Market: Market Revenue($bn) by EU5 Country, 2016
  • Figure 4.10: The EU5 Drug Discovery Outsourcing Market: Market Share(%) by Region, 2016
  • Figure 4.11: The EU5 Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.12: The EU5 Drug Discovery Outsourcing Market Forecast: CAGR(%) by Country, 2017-2022
  • Figure 4.13: The EU5 Drug Discovery Outsourcing Market Forecast: CAGR(%) by Country, 2022-2027
  • Figure 4.14: The EU5 Drug Discovery Outsourcing Market Forecast: CAGR(%) by Country, 2017-2027
  • Figure 4.15: The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares(%) by Country, 2022
  • Figure 4.16: The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares(%) by Country, 2027
  • Figure 4.17: The German Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.18: The UK Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.19: The French Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.20: The Italian Drug Discovery Outsourcing Market Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 4.21: The Spanish Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.22: The Japanese Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.23: The Chinese Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.24: The Chinese Population Demographics: Over 65 population and Forecast(millions) , 1950, 2010, 2050
  • Figure 4.25: The Indian Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.26: The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.27: The Russian Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.28: The South Korean Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.29: The Mexican Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 4.30: The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 5.1: Albany Molecular Research(AMRI): Historical Revenue($m), 2013-2016
  • Figure 5.2: AMRI(DDS) Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 5.3: Charles River Laboratories: Revenue($m), AGR(%), 2013-2016
  • Figure 5.4: Charles River Laboratories: Revenue Share(%) by Segment, 2016
  • Figure 5.5: Charles River Laboratories: Revenue($bn), 2015-2016
  • Figure 5.6: Charles River Laboratories: Revenue Share(%) by Business Segment, 2016
  • Figure 5.7: Charles River Laboratories Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 5.8: Covance: Historical Revenue($bn), 2010-2013
  • Figure 5.9: Covance: Revenue Share(%) by Segment, 2013
  • Figure 5.10: Cyprotex: Historical Revenue($m), 2011-2014
  • Figure 5.11: Cyprotex: Revenue Share(%) by Region, 2015
  • Figure 5.12: Domainex: Drug Pipeline by Indication, 2016
  • Figure 5.13: Evotec: Historical Revenue($m) 2013-2016
  • Figure 5.14: Evotec Forecast: Revenue($m), AGR(%), 2016-2027
  • Figure 5.15: QuintilesIMS: Historical Revenue($bn), AGR(%), 2012-2016
  • Figure 5.16: QuintilesIMS Forecast: Revenue($bn), AGR(%), 2016-2027
  • Figure 5.17: WuXiAppTec: Historical Revenue($m) for Laboratory Services, 2010-2014
  • Figure 5.18: WuXiAppTec Laboratory Services Forecast: Revenue($m), AGR(%), 2015-2026
  • Figure 6.1: The Drug Discovery Outsourcing Market: Drivers and Restraints, 2017-2027
  • Figure 6.2: Porter's Five Analysis of the Companion Diagnostics Market, 2017-2027
  • Figure 7.1: The Global Drug Discovery Outsourcing Market Forecast: Revenue($bn), 2016, 2022, 2027
  • Figure 7.2: The Global Drug Discovery Outsourcing Market Forecast: Revenue($bn) by Sector, 2016, 2022, 2027
  • Figure 7.3: The Drug Discovery Outsourcing Market Forecast: Revenue($bn) by Emerging Market, 2016, 2022 and 2027

List of Tables

  • Table 1.1: The Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 1.2: The Indian Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 2.1: Indication of Functions Outsourced in the Different Stages of the Drug R&D Process, 2016
  • Table 2.2:(Cont'd) Selected Drug Discovery Outsourcing Alliances, 2013-2017
  • Table 2.2:(Cont'd) Selected Drug Discovery Outsourcing Alliances, 2013-2017
  • Table 2.2: Selected Drug Discovery Outsourcing Alliances, 2013-2017
  • Table 3.1: PhMRA's Historical Estimate for its Member's Total R&D Spending($bn), 1980-2015
  • Table 3.2: The Global Drug Discovery Outsourcing Market: Revenue($bn), Market Share(%) by Sector, 2016
  • Table 3.3: The Global Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%) by Sector, 2016-2027
  • Table 3.4: The Global Drug Discovery Outsourcing Market: Revenue Share(%) by Sector, 2016 , 2022 and 2027
  • Table 3.5: The Chemistry Services Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%) by Sector, 2016-2027
  • Table 3.6: The Biology Services Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%) by Sector, 2016-2027
  • Table 3.7: The Lead Optimisation Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%) by Sector, 2016-2027
  • Table 3.8: Selected Source for Lead Compounds, 2016
  • Table 3.9: The Lead Identification and Screening Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.1: The Global Drug Discovery Outsourcing Market: Revenue($bn), Market Share(%) by Region, 2016
  • Table 4.2: The Global Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%) by Region, 2016-2027
  • Table 4.3: The Global Drug Discovery Outsourcing Market: Market Share(%) by Region, 2016, 2022, 2027
  • Table 4.4: The Global Drug Discovery Outsourcing Market Forecast: CAGR(%) by Region, 2017-2022, 2022-2027, 2017-2027
  • Table 4.5: The US Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.6: The US Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.7: The EU5 Drug Discovery Outsourcing Market: Revenue($bn), Market Share(%) by Region, 2016
  • Table 4.8: The EU5 Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.9: The EU5 Drug Discovery Outsourcing Market Forecast: CAGR(%) by Country, 2017-2022, 2022-2027, and 2017-2027
  • Table 4.10: The EU5 Drug Discovery Outsourcing Market: Market Shares(%) by Country, 2016, 2022, 2027
  • Table 4.11: The German Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.12: The German Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.13: The UK Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.14: The UK Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.15: The French Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.16: The French Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.17: The Italian Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.18: The Italian Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.19: The Spanish Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.20: The Spanish Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.21: The Japanese Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.22: The Japanese Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.23: The Chinese Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.24: The Chinese Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.25: The Indian Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.26: The Indian Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.27: The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.28: The Brazilian Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.29: The Russian Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.30: The Russian Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.31: The South Korean Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.32: The South Korean Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.33: The Mexican Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 4.34: The Mexican Drug Discovery Outsourcing Market Forecast: Market Size($bn), Rank, Market Share(%) and CAGR(%), 2016-2027
  • Table 4.35: The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 5.1: List of Key Participating Players in Drug Discovery Outsourcing Market
  • Table 5.2: Albany Molecular Research(AMRI): Historical Revenue($m), 2013-2016
  • Table 5.3: AMRI: Service Offerings and Descriptions, 2016
  • Table 5.4: AMRI: Drug Discovery and Development Programmes and Project Stage, 2015
  • Table 5.5: AMRI(DDS) Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.6: Aptuit: Services Offered and their Descriptions, 2016
  • Table 5.7: Charles River Laboratories: Services Offered by Segment, 2016
  • Table 5.8: Charles River Laboratories: Revenue($m), AGR(%), 2013-2016
  • Table 5.9: Charles River Laboratories: Revenue($m) by Segment, 2014-2016
  • Table 5.10: Charles River Laboratories: Revenue($bn) by Business Segment, 2015-2016
  • Table 5.11: Charles River Laboratories Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.12: Covance: Historical Revenue($bn) by Business Segment, 2010-2013
  • Table 5.13: Selected Cyprotex Partnerships, 2015
  • Table 5.14: Cyprotex: Historical Revenue($m), 2011-2014
  • Table 5.15: Cyprotex: Revenue($m), Revenue Share(%) by Region, 2015
  • Table 5.16: Cyprotex Selected Collaborations
  • Table 5.17: Evotec: Historical Revenue($m),(€m), 2013-2016
  • Table 5.18: Evotec: Discovery Pipeline, 2016
  • Table 5.19: Evotec Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.20: GenScript: Services Offered and Descriptions, 2016
  • Table 5.21: QuintilesIMS: Revenue($bn), AGR(%), 2012-2016
  • Table 5.22: QuintilesIMS Forecast: Revenue($bn), AGR(%), CAGR(%), 2016-2027
  • Table 5.23: Selcia: Drug Discovery Services Portfolio, 2016
  • Table 5.24: VivaBiotech: Service Offerings, 2016
  • Table 5.25: WuXiAppTec: Pharmaceutical Laboratory Services and Descriptions, 2016
  • Table 5.26: WuXiAppTec: Historical Revenue($m), AGR(%) by Business Segment, 2010-2014
  • Table 5.27: WuXiAppTec Laboratory Services Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 6.1: SWOT Analysis of the Drug Discovery Outsourcing Industry, 2017-2027
  • Table 7.1: The Global Drug Discovery Outsourcing Market Forecast:
  • Table 7.2: The Global Drug Discovery Outsourcing Market: Revenue($bn) by Sector, 2016, 2022, 2027
  • Table 7.3: The Drug Discovery Outsourcing Market Forecast: Revenue($bn) by Emerging Market, 2016, 2022 and 2027

Companies Listed

  • AbbVie
  • Actavis
  • Acurian
  • Advion Bioanalytical Labs
  • Albany Molecular Research(AMRI)
  • Apredica
  • Aptuit
  • Argenta
  • Ark Therapeutics
  • Astex
  • AstraZeneca
  • Auspherix
  • Bayer
  • Behrman Capital
  • BGI(Beijing Genomics Institute)
  • BioCity
  • Bio Pontis Alliance
  • BioDuro
  • BioFocus
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Cantab
  • Caprion Proteomics
  • Carlyle Group
  • Catalent
  • ChanTest
  • Charles River Laboratories
  • CHDI
  • CHDI Foundation
  • CONBA
  • Covance
  • Cyprotex
  • Domainex
  • Elan
  • Eli Lilly
  • Evotec
  • Exquiron Biotech
  • Forma Therapeutics
  • Galapagos
  • Genentech
  • GenScript
  • GlaxoSmithKline
  • Great Lakes Chemical Corp
  • Horizon
  • Hypha Discovery
  • IMI
  • Janssen Pharmaceutical
  • JingXin
  • Johnson & Johnson
  • Kellogg Company
  • Keucept
  • Knopp Biosciences
  • Laboratory Corporation of America
  • Laurus Labs
  • MedImmune
  • Merck
  • Next CODE Health
  • Parexel
  • Pharmaceutical Product Development(PPD)
  • Ono
  • Proteros Biostructures
  • Quintile
  • Roche
  • Sanofi
  • Selcia
  • Shionogi
  • Siena Biotech
  • The Babraham Institute
  • UCB
  • Viva Biotech
  • Vivo Path
  • WIL Research Laboratories
  • WuXi AppTec
  • WuXi PharmaTech

List of Organizations:

  • European Medicines Agency
  • Food Drug and Administration
  • Harvard Universtiy
  • Midwest Bio Research
  • Milner Therapeutics Institute and Consortium
  • Ministry of Health, Labor and Welfare
  • MIT
  • National Institutes of Health
  • PhRMA(Pharmaceutical Research and Manufacturers of America)
  • The Sanger Institute
  • University of Cambridge
  • University of Edinburgh
  • World Health Organization
Back to Top